PMV PHARMACEUTICALS, INC. Unrecognized Tax Benefits
PMV PHARMACEUTICALS, INC. (PMVP) had Unrecognized Tax Benefits of $4.03 million as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-06
- 2025-12-31: Unrecognized Tax Benefits $4.03M.
- 2024-12-31: Unrecognized Tax Benefits $3.26M.
- 2023-12-31: Unrecognized Tax Benefits $3.17M.
- 2022-12-31: Unrecognized Tax Benefits $2.44M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $4.03M 10-K · filed 2026-03-06 |
| 2024-12-31 | $3.26M 10-K · filed 2026-03-06 |
| 2023-12-31 | $3.17M 10-K · filed 2026-03-06 |
| 2022-12-31 | $2.44M 10-K · filed 2025-03-03 |
| 2021-12-31 | $1.65M 10-K · filed 2024-02-29 |
| 2020-12-31 | $877.00K 10-K · filed 2023-03-01 |
| 2019-12-31 | $543.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | $415.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |